Biohaven Pharmaceutical Holding Co Ltd.(BHVN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BHVN Biohaven Pharmaceutical Holding Co Ltd.

未开盘 03-25 16:00:00 EDT

8.61

+0.22

+2.62%

盘后8.75

+0.14+1.63%

18:39 EDT

最高8.80	最低8.47	成交量181.78万
今开8.53	昨收8.39	日振幅3.93%
总市值12.95亿	流通市值10.68亿	总股本1.50亿
成交额1,567万	换手率1.47%	流通股本1.24亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BHVN","market":"US","secType":"STK","nameCN":"Biohaven Pharmaceutical Holding Co Ltd.","latestPrice":8.61,"timestamp":1774468800000,"preClose":8.39,"halted":0,"volume":1817770,"hourTrading":{"tag":"盘后","latestPrice":8.75,"preClose":8.61,"latestTime":"18:39 EDT","volume":43463,"amount":374448.075,"timestamp":1774478372307,"change":0.14,"changeRate":0.01626,"amplitude":0.02108},"delay":0,"changeRate":0.02622169249106065,"floatShares":124000000,"shares":150417084,"eps":-6.864787,"marketStatus":"未开盘","change":0.22,"latestTime":"03-25 16:00:00 EDT","open":8.53,"high":8.8,"low":8.47,"amount":15667526.86484,"amplitude":0.039333,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.864787,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1774512000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1493870400000,"exchange":"NYSE","adjPreClose":8.39,"preHourTrading":{"tag":"盘前","latestPrice":8.48,"preClose":8.39,"latestTime":"09:25 EDT","volume":1254,"amount":10593.192588,"timestamp":1774445125048,"change":0.09,"changeRate":0.010727,"amplitude":0.035757},"postHourTrading":{"tag":"盘后","latestPrice":8.75,"preClose":8.61,"latestTime":"18:39 EDT","volume":43463,"amount":374448.075,"timestamp":1774478372307,"change":0.14,"changeRate":0.01626,"amplitude":0.02108},"volumeRatio":0.653504,"impliedVol":0.9296,"impliedVolPercentile":0.1673},"requestUrl":"/m/hq/s/BHVN","defaultTab":"news","newsList":[{"id":"1181629068","title":"Biohaven新型肌肉生长抑制素-激活素通路抑制剂Taldefgrobep Alfa二期肥胖研究完成患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1181629068","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181629068?lang=zh_cn&edition=full","pubTime":"2026-03-19 19:33","pubTimestamp":1773920020,"startTime":"0","endTime":"0","summary":"Biohaven制药控股公司宣布，其针对Taldefgrobep Alfa开展的二期肥胖临床研究已顺利完成患者招募工作。该创新疗法是一种新型肌肉生长抑制素-激活素通路抑制剂，此次研究进展标志着其在代谢疾病治疗领域迈出重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","BHVN","BK4139","LU1093756168.USD"],"gpt_icon":0},{"id":"2617343661","title":"Biohaven Ltd.2025财年实现净利润-7.39亿美元，同比增加12.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617343661","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617343661?lang=zh_cn&edition=full","pubTime":"2026-03-08 00:01","pubTimestamp":1772899273,"startTime":"0","endTime":"0","summary":"3月8日，Biohaven Ltd.公布财报，公告显示公司2025财年净利润为-7.39亿美元，同比增加12.65%；其中营业收入为0.00美元，每股基本收益为-6.86美元。从资产负债表来看，Biohaven Ltd.总负债3.99亿美元，其中短期债务5.76百万美元，资产负债比为1.14，流动比率为3.18。机构评级：截至2026年3月8日，当前有12家机构对Biohaven Ltd.目标价做出预测，其中目标均价为22.50美元，其中最低目标价为9.00美元，最高目标价为50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260308000141a6ad6d35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260308000141a6ad6d35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","LU1093756168.USD","BHVN","BK4139"],"gpt_icon":0},{"id":"2612264618","title":"Biohaven Ltd.盘中异动 临近午盘股价大跌5.03%报10.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612264618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612264618?lang=zh_cn&edition=full","pubTime":"2026-02-20 00:58","pubTimestamp":1771520285,"startTime":"0","endTime":"0","summary":"北京时间2026年02月20日00时58分，Biohaven Ltd.股票出现异动，股价急速下挫5.03%。截至发稿，该股报10.96美元/股，成交量49.5213万股，换手率0.37%，振幅5.20%。Biohaven Ltd.股票所在的生物技术行业中，整体跌幅为0.39%。Biohaven Ltd.公司简介：Biohaven Ltd 是一家临床阶段的生物制药公司，专注于免疫学、神经科学和肿瘤学等关键治疗领域的变革性治疗方法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220005805954179a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220005805954179a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","BK4139","LU1093756325.SGD","BHVN"],"gpt_icon":0},{"id":"2610647033","title":"Biohaven Ltd.盘中异动 快速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610647033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610647033?lang=zh_cn&edition=full","pubTime":"2026-02-09 23:42","pubTimestamp":1770651773,"startTime":"0","endTime":"0","summary":"北京时间2026年02月09日23时42分，Biohaven Ltd.股票出现波动，股价快速上涨5.26%。截至发稿，该股报12.21美元/股，成交量57.9876万股，换手率0.44%，振幅3.19%。Biohaven Ltd.股票所在的生物技术行业中，整体跌幅为0.63%。Biohaven Ltd.公司简介：Biohaven Ltd 是一家临床阶段的生物制药公司，专注于免疫学、神经科学和肿瘤学等关键治疗领域的变革性治疗方法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209234253a48fc80d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209234253a48fc80d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1093756168.USD","LU1093756325.SGD","BHVN"],"gpt_icon":0},{"id":"2605879424","title":"Biohaven Ltd.盘中异动 股价大涨5.05%报13.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605879424","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605879424?lang=zh_cn&edition=full","pubTime":"2026-01-22 23:35","pubTimestamp":1769096142,"startTime":"0","endTime":"0","summary":"北京时间2026年01月22日23时35分，Biohaven Ltd.股票出现异动，股价大幅拉升5.05%。截至发稿，该股报13.52美元/股，成交量54.7663万股，换手率0.41%，振幅6.12%。Biohaven Ltd.股票所在的生物技术行业中，整体涨幅为0.95%。Biohaven Ltd.公司简介：Biohaven Ltd 是一家临床阶段的生物制药公司，专注于免疫学、神经科学和肿瘤学等关键治疗领域的变革性治疗方法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122233542a6a134e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122233542a6a134e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","LU1093756168.USD","BHVN","BK4139"],"gpt_icon":0},{"id":"2603995362","title":"Biohaven Ltd.盘中异动 下午盘股价大涨5.13%报12.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603995362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603995362?lang=zh_cn&edition=full","pubTime":"2026-01-16 03:13","pubTimestamp":1768504398,"startTime":"0","endTime":"0","summary":"北京时间2026年01月16日03时13分，Biohaven Ltd.股票出现波动，股价急速拉升5.13%。截至发稿，该股报12.30美元/股，成交量187.554万股，换手率1.41%，振幅7.74%。Biohaven Ltd.股票所在的生物技术行业中，整体跌幅为0.74%。Biohaven Ltd.公司简介：Biohaven Ltd 是一家临床阶段的生物制药公司，专注于免疫学、神经科学和肿瘤学等关键治疗领域的变革性治疗方法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116031318953cf5eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116031318953cf5eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1093756325.SGD","LU1093756168.USD","BHVN"],"gpt_icon":0},{"id":"1137170088","title":"Biohaven癫痫药物前景超越抑郁症试验失利，市场聚焦新机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=1137170088","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137170088?lang=zh_cn&edition=full","pubTime":"2025-12-27 00:48","pubTimestamp":1766767713,"startTime":"0","endTime":"0","summary":"尽管Biohaven制药公司（BHVN）针对抑郁症治疗的BHV-7000二期研究未达到主要终点，雷蒙德·詹姆斯分析师指出，该公司仍蕴藏巨大潜力。分析师维持对该股的\"强力买入\"评级，因其更关注Biohaven将BHV-7000应用于癫痫治疗的开发计划。\n这款药物在癫痫治疗领域展现卓越前景，其安全性数据可能优于竞争药物阿泽塔克纳。分析师强调，Biohaven计划于2026年1月公布最新数据，并在上半年完成癫痫适应症的首次关键数据解读，此举有望显著提升短期估值。\n（本文根据市场讨论整理，不构成投资建议）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d018407bd33f27ba9ab8988ad29e6a0c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","BHVN","BK4139","LU1093756168.USD"],"gpt_icon":0},{"id":"2594990142","title":"美股盘前要闻一览","url":"https://stock-news.laohu8.com/highlight/detail?id=2594990142","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594990142?lang=zh_cn&edition=full","pubTime":"2025-12-26 21:37","pubTimestamp":1766756268,"startTime":"0","endTime":"0","summary":"蓝鲸新闻12月26日电，投资者需重点关注的美股市场财经要闻如下： 1、美国股指期货小幅波动，截至目前，道琼斯指数期货跌0.10%，标普500指数期货涨0.02%，纳斯达克100指数期货涨0.10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251226213912a47bea00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251226213912a47bea00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2471134523.USD","LU1814569148.SGD","LU2237443622.USD","LU0553294199.USD","LU0683600562.USD","LU0109392836.USD","LU0267386448.USD","IE00B4YYXB79.USD","TSLA","SG9999014575.USD","IE0009356076.USD","LU2237438978.USD","LU0096364046.USD","BK4501","LU1935043536.SGD","LU2089283258.USD","LU1699723380.USD","BK4559","LU1791710400.SGD","IE0004445239.USD","LU1066053197.SGD","LU0456855351.SGD","LU1066051225.USD","LU0170899867.USD","SG9999001424.SGD","LU1066051498.USD","LU2896262040.SGD","LU1261432733.SGD","IE00BZ1G4Q59.USD","SPY","LU2361044865.SGD","LU1989772923.USD","LU2458330169.SGD","LU2065170008.USD","SG9999002232.USD","LU0210536198.USD","IE00BFSS8Q28.SGD","LU1582986433.USD","IE00B19Z8W00.USD","LU2097344357.USD","LU1815336760.USD","LU2237443978.SGD","LU2357305700.SGD","LU0234570918.USD","IE00BJJMRX11.SGD","HK0000306685.HKD","SG9999014559.SGD","LU0053666078.USD","LU2417539215.USD","BK4588","LU0545039389.USD","LU1548497426.USD","LU0203201768.USD","LU1791710582.SGD","LU0528227936.USD","LU1232071149.USD","LU2271345857.HKD","LU1506573853.SGD","LU1934455277.USD","LU1934455863.HKD","LU0234572021.USD","LU2250418816.HKD","LU1242518857.USD","LU1989771016.USD","LU0787776722.HKD","LU1582986359.USD","LU1674673691.USD","LU2168563687.JPY","IE00BN29S564.USD","LU1868837300.USD","IE00BJLML261.HKD","IE00BLSP4239.USD","LU1868836914.USD","LU1291159041.SGD","SG9999014880.SGD","LU0323591593.USD","LU2028103732.USD","LU2746668461.USD","LU2471134879.HKD","LU2125154778.USD","LU0642271901.SGD","LU0882574139.USD","LU0345768740.USD","LU1804176565.USD","LU0203202063.USD","LU1732800096.USD","IE00BKVL7J92.USD","BK4504","IE00B19Z8X17.USD","LU2430703095.HKD","LU1718418525.SGD","IVV","BK4532","LU0494093205.USD","LU1629891620.HKD","LU2543165471.USD","LU2746668974.SGD","HK0000320264.USD","SDS","LU2471134796.USD","IE0004445015.USD","LU0784385170.HKD","LU0072462426.USD","LU1989764748.USD","LU0354030438.USD","LU2237443895.HKD","LU2860962120.EUR","LU2111349929.HKD","LU1069344957.HKD","IE00BJJMRY28.SGD","LU0210533765.USD","LU0124676726.USD","LU2452424414.USD","LU0726765562.USD","MESmain","LU1935042215.USD","BK4527","LU2471134952.CNY","LU2168564065.EUR","SG9999015945.SGD","LU0289739343.SGD","LU1720051108.HKD","LU1551013342.USD","LU2458330243.SGD","LU0210528500.USD","SG9999014542.SGD","BK4566","BK4574","LU0345768153.USD","UPRO","LU2023250504.SGD","IE00BFSS7M15.SGD","LU1496350171.SGD","LU0048584097.USD","LU0320765059.SGD","LU1206712785.SGD","LU1823568750.SGD","LU1116320737.USD","SG9999015952.SGD","IE0003U64NQ7.SGD",".SPX","SG9999017495.SGD","LU2065171311.SGD","IE00BK4W5M84.HKD","LU0661504455.SGD","IE00B3SWFQ91.USD","LU0784384876.USD","LU0353189763.USD","LU2242650005.HKD","IE0004086264.USD","LU1551013425.SGD","SG9999014914.USD","LU2286300806.USD","SG9999018857.SGD","LU2381873111.SGD","LU2063271972.USD","BK4507","LU0011850046.USD","LU0795875086.SGD","LU0096362180.USD","LU0077335932.USD","BK4576","BK4553","LU0476273544.USD","LU0070217475.USD","LU2097344431.USD","LU1066051811.HKD","LU1674673428.USD","LU0057025933.USD","LU2237443382.USD","LU1244550494.USD","LU1235294995.USD","IE00B3S45H60.SGD","LU1815333072.USD","IE0001KFT4U8.USD","LU0823434740.USD","LU1496350502.SGD","LU1868836757.USD","LU0444971666.USD","SG9999015358.SGD","BK4533","LU0466842654.USD","IE00B5949003.HKD","LU0061474960.USD","LU0823434583.USD","LU0417517546.SGD","LU0251132253.USD","LU1778281490.HKD","IE00B7KXQ091.USD","BK4592","LU1127390331.HKD","HK0000320223.HKD","IE00BJTD4V19.USD","LU0689626769.HKD","IE00B1BXHZ80.USD","LU2403377893.USD","LU2487616109.SGD","LU2461242641.AUD","LU1267930730.SGD","LU2750360997.AUD","LU0265550359.USD","LU0964807845.USD","LU0314104364.USD","LU1974910355.USD","LU2430703178.SGD","BK4573","LU2430703251.USD","LU0708995401.HKD","LU0724617625.USD","LU1244550221.USD","HK0000306701.USD","LU0912757837.SGD","LU2552382215.SGD","LU0943347566.SGD","LU0786609619.USD","LU1244550577.SGD","LU1037948897.HKD","BK4575","BK4512","LU0314106906.USD","LU0788109477.HKD","LU0127658192.USD","LU0795875169.SGD","LU1935042991.SGD","LU0069063385.USD","LU0949170426.SGD","LU0957791311.USD","SG9999015978.USD","LU1046421795.USD","LU0154236417.USD","LU0082616367.USD","SPXU","LU0823421416.USD","BK4554","LU1642822529.SGD","LU1280957306.USD","LU0965509010.AUD","LU0061475181.USD","ESmain","BK4579","IE000W1ABFV2.USD","LU2023250330.USD","LU2552382058.USD","LU0861579265.USD","LU1839511570.USD","LU1003077747.HKD","LU0353189680.USD","LU0784383803.USD","LU2191332357.HKD","LU2087625088.SGD","LU2133065610.SGD","LU0097036916.USD","LU0158827948.USD","IE00B775SV38.USD","LU0289961442.SGD","IE00BSNM7G36.USD","LU0640476718.USD","LU2168564222.USD","SG9999014898.SGD","LU2237443549.SGD","LU0784385840.USD","LU1084165304.USD","LU0719512351.SGD","LU0889565833.HKD","LU2065169927.USD","LU1989772840.SGD","GB00BDT5M118.USD","IE00BWXC8680.SGD","SG9999014567.USD","LU1301847155.USD","LU1803068979.SGD","LU0820562030.AUD","LU1366333091.USD","LU1914381329.SGD","IE00BBT3K403.USD","LU0965509283.SGD","LU2054465674.USD","LU1852331112.SGD","LU2077746001.SGD","LU2092937148.SGD","IE00BJTD4N35.SGD","LU1989764664.SGD","LU2756315664.SGD","LU0444973449.USD","SG9999014906.USD","LU2083900584.USD","BK4585","LU1145028129.USD","LU0738911758.USD","LU0215105999.USD","LU2023251221.USD","LU1720051017.SGD","LU2265009873.SGD","LU0985320562.USD","LU1316542783.SGD","LU2108987350.USD","LU1242518931.SGD","LU2420271590.USD","LU2361045086.USD","LU0965508806.USD","LU0265550946.USD","LU0345770308.USD","LU2756315318.SGD","LU2247934214.USD","LU0345769128.USD","LU0198837287.USD","LU1917777945.USD","LU2089284900.SGD","LU2361044949.HKD","LU2106854487.HKD","LU2168564495.EUR","LU2213496289.HKD","LU1037948541.HKD","LU2505996509.AUD","IE0009G5SDU7.USD","LU1935042488.USD","BK4571","LU1035775433.USD","LU1935043023.USD","LU2168564149.EUR","LU2456880835.USD","SG9999015986.USD","IE00BN8TJ469.HKD","MACW.SI","BK4598","LU0256863902.USD","LU2347655156.SGD","OEF","SH","LU0472753341.HKD","LU0823421333.USD","BHVN","IE000KEQY171.SGD","IE00B19Z9505.USD","LU2462157665.USD","LU0942090050.USD","IE00BLSP4452.SGD","BK4550","LU0949170772.SGD","LU2237443465.HKD","LU2092627202.USD","LU2242649171.HKD","LU0511384066.AUD","LU0868494617.USD","LU0149725797.USD","LU0672654240.SGD","IE00BK4W5L77.USD","LU0308772762.SGD","LU1119994496.HKD","LU0820561909.HKD","LU1366192091.USD","IE00B1XK9C88.USD","LU1116320901.HKD","OEX","LU2505996681.GBP","LU2023250843.SGD","LU2360106780.USD","LU0689472784.USD","BK4515","LU2602419157.SGD","BK4581","LU0345769631.USD","IE0034235303.USD","BK4505","BK4534","BK4170","LU0109391861.USD","SGXZ31699556.SGD","LU0316494557.USD","LU2552382132.HKD","SG9999000418.SGD","LU2347655073.USD","LU0354030511.USD","LU2592432038.USD","IE00B775H168.HKD","LU0979878070.USD","LU2236285917.USD","IE00BKDWB100.SGD","LU0158827781.USD","LU2065171402.SGD","LU0957808578.USD","LU1582987324.SGD","LU1868837136.USD","LU0238689110.USD","LU1868836591.USD","LU2087621335.USD","LU0256863811.USD","LU0868494708.USD","SG9999018865.SGD","LU1571399168.USD","LU0965509101.SGD","LU0157215616.USD","LU2360032135.SGD","LU1732799900.SGD","LU1582987597.SGD","LU1934455194.USD","IE0005OL40V9.USD","IE000YTNTUN2.SGD","LU1206713676.USD","LU0056508442.USD","LU0080751232.USD","IE000ITXATA3.USD","LU2125154935.USD","SSO","LU0820561818.USD","LU2750360641.GBP","LU0345770993.USD","SG9999002224.SGD","LU0079474960.USD","IE0004091025.USD","LU0348723411.USD","SG9999015341.SGD","IE00B4JS1V06.HKD"],"gpt_icon":1},{"id":"2594629182","title":"抑郁症新药II期试验失败，Biohaven(BHVN.US)盘前暴跌近13%!华尔街为何集体“辩护”?","url":"https://stock-news.laohu8.com/highlight/detail?id=2594629182","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594629182?lang=zh_cn&edition=full","pubTime":"2025-12-26 21:25","pubTimestamp":1766755503,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，尽管华尔街分析师在回应Biohaven平安夜发布的公告时为其辩护，但这家生物科技公司周五盘前仍下跌近13%——其抗抑郁候选药物BHV-7000的一项II期临床试验宣告失败。据报道，花旗分析师Samantha Semenkow给予Biohaven“买入”评级。他指出，虽然试验未达终点令人失望，但其公司给予Biohaven“与大盘持平”评级，原因正是“近年来临床试验执行难度加大以及安慰剂效应增强”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386135.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"抑郁症新药II期试验失败，Biohaven(BHVN.US)盘前暴跌近13%!华尔街为何集体“辩护”?","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1093756168.USD","LU1093756325.SGD","BHVN","BK4139"],"gpt_icon":0},{"id":"1170446479","title":"美股夜盘 | 2倍做多白银ETF涨超8%，现货白银再刷新高；太空概念股Sidus Space续涨逾24%","url":"https://stock-news.laohu8.com/highlight/detail?id=1170446479","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170446479?lang=zh_cn&edition=full","pubTime":"2025-12-26 09:11","pubTimestamp":1766711516,"startTime":"0","endTime":"0","summary":"12月26日，美股夜盘时段，2倍做多白银ETF涨超8%，现货白银首次突破74美元/盎司创新高，日涨幅扩大至3%，今年累涨近150%；太空概念股Sidus Space涨超24%，上一交易日暴涨逾33%！公司获得导弹防御局SHIELD无限期交付/无限期数量合同计划；Biohaven跌超16%，其试验性抑郁症药物在一项中期试验中未能达到主要目标；","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"bdfcc80a03e3cfde323a69db253572cb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGQ","SIDU","BHVN"],"gpt_icon":0},{"id":"2594863122","title":"Biohaven试验性抑郁症药物在中期试验中未能达到主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2594863122","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594863122?lang=zh_cn&edition=full","pubTime":"2025-12-25 09:36","pubTimestamp":1766626569,"startTime":"0","endTime":"0","summary":"12月25日，$Biohaven$公司周三表示，其试验性抑郁症药物在一项中期试验中未能达到主要目标。该公司股价在盘后交易中下跌16%，今年以来累计跌幅已超过70%。在针对重度抑郁症患者进行的为期六周的试验中，Biohaven的药物BHV-7000与安慰剂相比，在根据蒙哥马利抑郁评定量表变化评估的抑郁症状减轻方面未显示出显著差异。","market":"us","thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385746.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Biohaven抑郁症药物中期试验失败，盘后下跌16%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1093756325.SGD","LU1093756168.USD","BHVN","BK4139"],"gpt_icon":0},{"id":"1100042719","title":"Biohaven 更新Bhv-7000在重度抑郁症的第二阶段概念验证研究进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1100042719","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100042719?lang=zh_cn&edition=full","pubTime":"2025-12-25 02:01","pubTimestamp":1766599271,"startTime":"0","endTime":"0","summary":"Biohaven 更新Bhv-7000在重度抑郁症的第二阶段概念验证研究进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","BHVN","BK4139","LU1093756325.SGD"],"gpt_icon":0},{"id":"2587632557","title":"Biohaven Ltd.盘中异动 股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2587632557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587632557?lang=zh_cn&edition=full","pubTime":"2025-11-28 23:23","pubTimestamp":1764343388,"startTime":"0","endTime":"0","summary":"北京时间2025年11月28日23时23分，Biohaven Ltd.股票出现波动，股价大幅拉升5.22%。截至发稿，该股报9.98美元/股，成交量43.0287万股，换手率0.32%，振幅4.07%。Biohaven Ltd.股票所在的生物技术行业中，整体涨幅为0.27%。Biohaven Ltd.公司简介：Biohaven Ltd 是一家临床阶段的生物制药公司，专注于免疫学、神经科学和肿瘤学等关键治疗领域的变革性治疗方法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112823230897851021&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112823230897851021&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","BHVN","BK4139","LU1093756168.USD"],"gpt_icon":1},{"id":"1115529931","title":"Biohaven宣布拟进行公众股票发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1115529931","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115529931?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:22","pubTimestamp":1763572929,"startTime":"0","endTime":"0","summary":"11月12日 - Biohaven Ltd：*BIOHAVEN宣布拟进行公众普通股发行*。Biohaven Ltd：已开始进行价值1.5亿美元的普通股承销公开发行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHVN","LU1093756325.SGD","BK4139","LU1093756168.USD"],"gpt_icon":0},{"id":"1183835191","title":"异动解读 | Biohaven宣布1.5亿美元股票发行计划，股价盘前大跌6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=1183835191","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183835191?lang=zh_cn&edition=full","pubTime":"2025-11-12 18:02","pubTimestamp":1762941755,"startTime":"0","endTime":"0","summary":"生物制药公司Biohaven Pharmaceutical Holding Co Ltd.今日盘前大跌6.46%，引发投资者广泛关注。这一跌幅主要源于公司最新宣布的1.5亿美元股票发行计划。据悉，Biohaven计划发行价值1.5亿美元的新股，用于一般企业用途。值得注意的是，Biohaven目前已发行约1.059亿股，市值约9亿美元。11月5日，美国食品药品监督管理局拒绝批准Biohaven用于治疗脊髓小脑共济失调的实验性药物troriluzole，导致公司股价暴跌40%。投资者将密切关注Biohaven后续的融资进展及其对公司发展的影响。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BHVN"],"gpt_icon":0},{"id":"1197681055","title":"异动解读 | Biohaven制药夜盘大跌6.10%，宣布1.5亿美元股票发行计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1197681055","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197681055?lang=zh_cn&edition=full","pubTime":"2025-11-12 09:04","pubTimestamp":1762909490,"startTime":"0","endTime":"0","summary":"生物制药公司Biohaven Pharmaceutical Holding Co Ltd.在夜盘交易中大跌6.10%，引发投资者广泛关注。这一跌幅主要源于公司最新宣布的1.5亿美元股票发行计划。据悉，Biohaven计划发行价值1.5亿美元的新股，用于一般企业用途。值得注意的是，Biohaven目前已发行约1.059亿股，市值约9亿美元。11月5日，美国食品药品监督管理局拒绝批准Biohaven用于治疗脊髓小脑共济失调的实验性药物troriluzole，导致公司股价暴跌40%。投资者将密切关注Biohaven后续的融资进展及其对公司发展的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BHVN"],"gpt_icon":0},{"id":"1179401425","title":"异动解读 | Biohaven制药盘后暴跌7.51%，宣布1.5亿美元股票发行计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1179401425","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179401425?lang=zh_cn&edition=full","pubTime":"2025-11-12 06:06","pubTimestamp":1762898786,"startTime":"0","endTime":"0","summary":"周二盘后交易中，Biohaven制药控股有限公司股价大幅下挫7.51%，引发投资者关注。这家生物制药公司刚刚宣布了一项1.5亿美元的股票发行计划，旨在为公司的一般企业用途筹集资金。Biohaven目前已发行约1.059亿股，市值约9亿美元。此次股票发行计划的消息无疑加剧了投资者对公司股权稀释的担忧。Biohaven近期面临重大挫折。尽管如此，在18位分析师中，仍有14位给予Biohaven\"强力买入\"或\"买入\"评级，其余给予\"持有\"评级。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BHVN"],"gpt_icon":0},{"id":"2582027188","title":"Biohaven Ltd.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582027188","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582027188?lang=zh_cn&edition=full","pubTime":"2025-11-11 02:09","pubTimestamp":1762798153,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日02时09分，Biohaven Ltd.股票出现波动，股价急速下跌5.08%。截至发稿，该股报7.84美元/股，成交量190.374万股，换手率1.80%，振幅7.89%。Biohaven Ltd.股票所在的生物技术行业中，整体涨幅为0.53%。Biohaven Ltd.公司简介：Biohaven Ltd 是一家临床阶段的生物制药公司，专注于免疫学、神经科学和肿瘤学等关键治疗领域的变革性治疗方法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511110209139760bef1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511110209139760bef1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","GLTO","LU1093756168.USD","BHVN","BK4139"],"gpt_icon":0},{"id":"2581080079","title":"新药上市遭FDA拒批，Biohaven(BHVN.US)股价暴跌40%!美银下调评级至“中性”","url":"https://stock-news.laohu8.com/highlight/detail?id=2581080079","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581080079?lang=zh_cn&edition=full","pubTime":"2025-11-06 10:12","pubTimestamp":1762395154,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周三，Biohaven股价暴跌40.22%，创下52周新低。此前该公司发布消息称，美国食品药品监督管理局对其主要资产Vyglxia的上市申请发出完整回复函，明确拒绝批准该药物。然而，此次CRL的出具令Biohaven措手不及。尽管如此，Biohaven仍表示将继续与FDA保持沟通，推进Vyglxia的监管审批进程，并期待与监管机构会面讨论后续行动。与此同时，Biohaven宣布启动重组计划，暂停或推迟非优先研发管线项目，预计将实现年度研发支出减少约60%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1365852.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"新药上市遭FDA拒批，Biohaven(BHVN.US)股价暴跌40%!美银下调评级至“中性”","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BHVN"],"gpt_icon":0},{"id":"2581593510","title":"Biohaven Ltd.股价重挫34.84% 市值跌3.35亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581593510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581593510?lang=zh_cn&edition=full","pubTime":"2025-11-05 22:32","pubTimestamp":1762353179,"startTime":"0","endTime":"0","summary":"北京时间2025年11月05日22时32分，Biohaven Ltd.股票出现异动，股价大幅下跌34.84%。截至发稿，该股报9.09美元/股，成交量449.572万股，换手率4.25%，振幅7.74%。Biohaven Ltd.股票所在的生物技术行业中，整体跌幅为0.47%。Biohaven Ltd.公司简介：Biohaven Ltd 是一家临床阶段的生物制药公司，专注于免疫学、神经科学和肿瘤学等关键治疗领域的变革性治疗方法的发现、开发和商业化。消息层面，截至22时32分，《TD Cowen维持Biohaven买入评级，下调目标价至15美元》资讯为影响Biohaven Ltd.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105223300a48adfb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105223300a48adfb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BHVN","LU1093756168.USD","LU1093756325.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biohaven.com","stockEarnings":[{"period":"1week","weight":-0.0528},{"period":"1month","weight":-0.2565},{"period":"3month","weight":-0.2035},{"period":"6month","weight":-0.426},{"period":"1year","weight":-0.7118},{"period":"ytd","weight":-0.2374}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":-0.0375},{"period":"3month","weight":-0.0486},{"period":"6month","weight":-0.0076},{"period":"1year","weight":0.1414},{"period":"ytd","weight":-0.0368}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Biohaven Ltd.是一家于2022年5月2日在英属维尔京群岛注册成立的英属维尔京群岛商业有限公司。该公司是一家生物制药公司，专注于关键治疗领域改变生命的治疗方法的发现、开发和商业化，包括免疫学、神经科学和肿瘤学。该公司正在推进创新疗法组合，利用经过验证的药物开发经验和多个专有药物开发平台。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.071849},{"month":2,"riseRate":0.222222,"avgChangeRate":-0.026101},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.119093},{"month":4,"riseRate":0.5,"avgChangeRate":0.0146},{"month":5,"riseRate":0.625,"avgChangeRate":0.144142},{"month":6,"riseRate":0.555556,"avgChangeRate":0.056007},{"month":7,"riseRate":0.555556,"avgChangeRate":0.010799},{"month":8,"riseRate":0.666667,"avgChangeRate":0.043364},{"month":9,"riseRate":0.777778,"avgChangeRate":0.09598},{"month":10,"riseRate":0.555556,"avgChangeRate":-0.072057},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.042561},{"month":12,"riseRate":0.555556,"avgChangeRate":0.054983}],"exchange":"NYSE","name":"Biohaven Pharmaceutical Holding Co Ltd.","nameEN":"Biohaven Pharmaceutical Holding Co Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biohaven Pharmaceutical Holding Co Ltd.(BHVN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Biohaven Pharmaceutical Holding Co Ltd.(BHVN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Biohaven Pharmaceutical Holding Co Ltd.,BHVN,Biohaven Pharmaceutical Holding Co Ltd.股票,Biohaven Pharmaceutical Holding Co Ltd.股票老虎,Biohaven Pharmaceutical Holding Co Ltd.股票老虎国际,Biohaven Pharmaceutical Holding Co Ltd.行情,Biohaven Pharmaceutical Holding Co Ltd.股票行情,Biohaven Pharmaceutical Holding Co Ltd.股价,Biohaven Pharmaceutical Holding Co Ltd.股市,Biohaven Pharmaceutical Holding Co Ltd.股票价格,Biohaven Pharmaceutical Holding Co Ltd.股票交易,Biohaven Pharmaceutical Holding Co Ltd.股票购买,Biohaven Pharmaceutical Holding Co Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biohaven Pharmaceutical Holding Co Ltd.(BHVN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Biohaven Pharmaceutical Holding Co Ltd.(BHVN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}